Search Results 181-190 of 30627 for Ovarian

  1. Kristina A. Butler, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

    Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) — Mayo Clinic. · Noninvasive detection of cancer. · Gynecologic cancer ...

  2. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

    Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ...

  3. Patient Advocacy Advisory Committee - Mayo Clinic Research

    The Patient Advocacy Advisory Committee in the Mayo Clinic Ovarian Cancer SPORE brings together researchers and patients to improve outcomes and survival.

  4. Clinical trials - Oncology (Medical)

    ... ovarian cancer that responds at first to treatment with drugs that contain ... Adding abemaciclib to olaparib may work better to treat recurrent platinum- ...

  5. Overview - Immunometabolism and Cancer Immunology Laboratory - Mayo Clinic Research

    The Immunometabolism and Cancer Immunology Lab of Marion R. Curtis, Ph.D., at Mayo Clinic studies the tumor microenvironment for ovarian cancer ...

  6. Carrie L. Langstraat, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Carrie L. Langstraat, M.D., studies ovarian cancer outcomes and the use of AI to more accurately distinguish between cancerous and ...

  7. Enemy of My Enemy - Mayo Clinic News Network

    Measles has long been our enemy but with modification it transforms into a weapon against ovarian cancer. Rene Maleski knew it was bad news when the young ...

  8. Broad Evidence of Systemic Immune Activation in Long Term Survivors of Advanced Ovarian Cancer - Mayo Clinic

    The purpose of this study is to determine if long-term ovarian cancer survivors after receipt of a vaccine targeting folate receptor alpha will have persistent ...

  9. Novel Gene Drives Development of Different Types of Ovarian Cancer, Mayo Led Study Finds

    Ovarian cancer is the most common cause of death from gynecological cancers in the U.S.. In their study, Dr. Goode and her collaborators showed that variations ...

  10. A Study to Measure Anti-Mullerian Hormone for the Prediction of Response to Ovarian Stimulation - Mayo Clinic

    ... ovarian response to controlled ovarian stimulation in women presenting to general invitro fertilization clinics for evaluation. Participation eligibility.